These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34366626)

  • 1. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.
    Muñoz AE; Pollarsky FD; Marino M; Cartier M; Vázquez H; Salgado P; Romero G
    World J Gastroenterol; 2021 Jul; 27(28):4639-4652. PubMed ID: 34366626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
    Kaplan DE; Mehta R; Garcia-Tsao G; Albrecht J; Aytaman A; Baffy G; Bajaj J; Hernaez R; Hunt K; Ioannou G; Johnson K; Kanwal F; Lee TH; Monto A; Pandya P; Schaubel D; Taddei TH
    Contemp Clin Trials; 2021 May; 104():106367. PubMed ID: 33771685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
    Abraldes JG; Villanueva C; Aracil C; Turnes J; Hernandez-Guerra M; Genesca J; Rodriguez M; Castellote J; García-Pagán JC; Torres F; Calleja JL; Albillos A; Bosch J;
    Gastroenterology; 2016 May; 150(5):1160-1170.e3. PubMed ID: 26774179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of statins in the diseases of the liver.
    Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
    World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Pose E; Napoleone L; Amin A; Campion D; Jimenez C; Piano S; Roux O; Uschner FE; de Wit K; Zaccherini G; Alessandria C; Angeli P; Bernardi M; Beuers U; Caraceni P; Durand F; Mookerjee RP; Trebicka J; Vargas V; Andrade RJ; Carol M; Pich J; Ferrero J; Domenech G; Llopis M; Torres F; Kamath PS; Abraldes JG; Solà E; Ginès P
    Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):31-41. PubMed ID: 31607677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.
    Gu Y; Yang X; Liang H; Li D
    BMC Gastroenterol; 2019 Dec; 19(1):231. PubMed ID: 31888534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins: Old drugs as new therapy for liver diseases?
    Pose E; Trebicka J; Mookerjee RP; Angeli P; Ginès P
    J Hepatol; 2019 Jan; 70(1):194-202. PubMed ID: 30075229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.
    Pfisterer N; Schwarz M; Schwarz C; Putre F; Ritt L; Riedl F; Hartl L; Jachs M; Mandorfer M; Madl C; Trauner M; Reiberger T
    PLoS One; 2024; 19(6):e0302811. PubMed ID: 38870117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Muñoz AE; Pollarsky F; Marino M; Cartier M; Míguez C; Vázquez H; Álvarez D; Salgado P; Romero G
    Dig Dis Sci; 2021 Sep; 66(9):3199-3208. PubMed ID: 33033975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
    Pollo-Flores P; Soldan M; Santos UC; Kunz DG; Mattos DE; da Silva AC; Marchiori RC; Rezende GF
    Dig Liver Dis; 2015 Nov; 47(11):957-63. PubMed ID: 26321186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients.
    Wan S; Huang C; Zhu X
    BMJ Open; 2019 Jul; 9(7):e030038. PubMed ID: 31315875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis.
    Sung S; Al-Karaghouli M; Kalainy S; Cabrera Garcia L; Abraldes JG
    BMC Gastroenterol; 2021 Mar; 21(1):120. PubMed ID: 33726685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
    Vadera S; Yong CWK; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012673. PubMed ID: 31220333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
    Vargas JI; Arrese M; Shah VH; Arab JP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use in patients with cirrhosis: a retrospective cohort study.
    Kumar S; Grace ND; Qamar AA
    Dig Dis Sci; 2014 Aug; 59(8):1958-65. PubMed ID: 24838495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
    Sharpton SR; Loomba R
    Hepatology; 2023 Dec; 78(6):1896-1906. PubMed ID: 37013380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.